Real-time enrollment status for this lama2-md \(merosin deficient congenital muscular dystrophy, mdc1a\) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:50 AM UTC
| NCT Number | NCT06503367 |
| Recruiting Status | Recruiting |
| Condition | LAMA2-MD \(Merosin Deficient Congenital Muscular Dystrophy, MDC1A\) |
| Phase | Clinical Trial |
| Target Enrollment | 44 participants |
| Active Locations | 14 sites in the US |
| Sponsor | Nationwide Children's Hospital |
| Last Updated on CT.gov | April 8, 2026 (Apr 8, 2026) |
As of July 13, 2026: Clinical trial NCT06503367 is currently recruiting participants. This clinical trial study for lama2-md \(merosin deficient congenital muscular dystrophy, mdc1a\) is actively seeking new participants at 14 locations across the United States. The study is sponsored by Nationwide Children's Hospital. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06503367 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06503367 was last updated Apr 8, 2026 (April 8, 2026). HelloStudys verifies this status automatically.